Hologic, Inc.
HOLX · NASDAQ
9/27/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.06 | 0.30 | -0.58 | -0.43 |
| FCF Yield | 6.03% | 5.96% | 5.26% | 12.31% |
| EV / EBITDA | 15.57 | 15.20 | 15.58 | 7.95 |
| Quality | ||||
| ROIC | 7.35% | 9.84% | 5.47% | 16.45% |
| Gross Margin | 61.00% | 55.28% | 51.40% | 61.64% |
| Cash Conversion Ratio | 1.87 | 1.63 | 2.31 | 1.63 |
| Growth | ||||
| Revenue 3-Year CAGR | 0.58% | -6.07% | -10.56% | 8.79% |
| Free Cash Flow Growth | -19.64% | 27.08% | -54.92% | -7.16% |
| Safety | ||||
| Net Debt / EBITDA | 0.65 | 0.38 | 0.16 | 0.28 |
| Interest Coverage | 16.73 | 7.23 | 6.02 | 17.25 |
| Efficiency | ||||
| Inventory Turnover | 2.35 | 2.65 | 3.17 | 2.99 |
| Cash Conversion Cycle | 164.39 | 150.76 | 139.09 | 129.71 |